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studies – mainly in mice – animals exposed to short-term 
hypoxia accumulated inflammatory cells in multiple organs 
and showed elevated cytokines in the blood. Comparable 
studies were performed in humans, mainly in healthy moun-
taineers. Recently, we reported on the association between 
IBD flare-up episodes and antecedent journeys to high-alti-
tude region and aircraft travels. According to these findings, 
we concluded that flights and stays at high altitudes of 
>2,000 mg are a risk factor for increased disease activity in 
IBD. To evaluate the potential influence of hypoxia on the 
course of IBD on a biomolecular level and to test the effects 
of hypoxia under standardized conditions, we initiated a 
prospective and controlled investigation in both healthy 
controls and IBD patients in stable remission. The study par-
ticipants underwent a 3-hour exposure to hypoxic condi-
tions simulating an altitude of 4,000 m above sea level in a 
hyperbaric pressure chamber and clinical parameters as well 
as blood and stool samples were collected at several time 
points. The first results of this study are expected in the near 
future.  © 2016 S. Karger AG, Basel 
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 Abstract 
 The importance of environmental factors in the pathogen-
esis including their disease-modifying potential are increas-
ingly recognized in inflammatory bowel disease (IBD) pa-
tients, largely driven by the perception that the prevalence 
and incidence of IBD are on the rise within the last few years, 
especially in non-western countries. One of those factors is 
believed to be hypoxia. The role of hypoxia as a modifying 
or even causative factor in the genesis and maintenance of 
inflammation has been increasingly elucidated in recent 
years. Hypoxia is believed to be a main inducing factor of in-
flammation. This has been studied in different animal exper-
iments as well as in humans exposed to hypoxia. In several 
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 Background 
 The crucial role of hypoxia as an inductor of inflam-
mation has been studied extensively in animal experi-
ments as well as in humans exposed to hypoxia. In sev-
eral studies – mainly in mice – animals exposed to short-
term hypoxia accumulated inflammatory cells in multiple 
organs and showed elevated cytokines in the blood  [1–5] . 
Comparable studies were performed in humans, mainly 
in healthy mountaineers. One study, for example, inves-
tigated healthy volunteers who had spent 3 nights at an 
elevation of 3,400 m above sea level  [6] . In those individ-
uals, an increase of different cytokines such as IL-6, IL-6 
receptor and CRP in blood was detected, suggesting an 
important role of hypoxia in inflammation. Other studies 
investigated the impact of hypoxia on intestinal transport 
proteins, sleep, nutrition, exercise capacity, lung func-
tion, lipid metabolism and gastric emptying in healthy 
mountaineers  [7–9] . Furthermore, it is well known that 
exposure to high altitudes may lead to gastric and duode-
nal erosions and ulcer formation with consecutive gastro-
intestinal bleeding  [10, 11] .
 Our own group performed a study in which healthy 
volunteer mountaineers first received an (unsedated) en-
doscopy at baseline in Zurich. With the sole exception of 
one subject with reflux esophagitis, all subjects revealed 
normal endoscopic findings. After that, the study partici-
pants went to an altitude of 4,500 above sea level, where 
2 further endoscopies were performed. At day 2 (the time 
of the second endoscopy, performed in 18 subjects), ab-
normal endoscopic findings were observed in 28% of sub-
jects including hemorrhagic gastritis/duodenitis in 1 sub-
ject and duodenal erosions/ulcers in 4 subjects. Strikingly 
at day 4 (time of third endoscopic examination), the 
number of endoscopic abnormalities was as high as 61%, 
that is, 16 out of 23 patients showed signs of gastrointes-
tinal inflammation such as erosions/ulcers in the duode-
num or stomach, hemorrhagic gastritis/duodenitis and 
reflux esophagitis. These results clearly implicate that 
even in experienced mountaineers hypoxia has profound 
effects on the gastrointestinal epithelium already after a 
period of 2 and 4 days, respectively, with exposure to hy-
poxic conditions  [12] . Hypoxia has also been studied as a 
disease modifying factor and pro-inflammatory stimulus 
in several disease states, including in IBD, rheumatoid 
arthritis and cancer  [13–18] . Even with regard to solid 
organ transplantation, hypoxia and consecutive ischemia 
has been identified as an important driver of inflamma-
tion, which ultimately may lead to graft failure  [19] . The 
inter-relationship between hypoxia and inflammation 
does not appear to be unilateral but rather reciprocal, in 
that not only hypoxia can promote inflammation but also 
represent a consequence of the latter, for instance by im-
pairment of blood flow by tissue edema or formation of 
reactive oxygen species which in turn may lead to oxygen 
depletion  [20] . In the gut, a considerably steep and unique 
oxygen gradient can be observed in high proximity be-
tween the bowel lumen presenting an almost anaerobe 
compartment toward the highly perfused and oxygen-
rich intestinal epithelium  [21] . Thus, intestinal epithelial 
cells are continuously facing hypoxemia in the bowel lu-
men  [20] . The metabolic integrity of the intestinal mu-
cosa is regulated by different effectors, such as intestinal 
microbiota, blood perfusion to the intestine and tissue 
oxygenation. However, even in the physiological state, 
there is a considerable fluctuation in oxygen partial pres-
sure, due to the significant shifts in tissue perfusion for 
instance in the postprandial state  [20] . In general, epithe-
lial barrier integrity and absorptive functions are regu-
lated by oxygen and substantial metabolic shifts are to be 
observed at sites of mucosal inflammation, where nutri-
tional supply and oxygen are depleted, with consecutive 
hypoxia, hypoglycemia and lactate accumulation result-
ing in a decreasing pH  [21] . A variety of processes in-
volved in the pathophysiology of inflammation are char-
acterized by a high demand and consumption of oxygen, 
including cell migration to inflammatory foci  [22] , phago-
cytosis  [23] and bacterial killing  [24] (often mediated by 
the generation of reactive oxygen species).
 Key Messages 
 As a sequel of decreasing oxygen concentration, the 
expression of hypoxia-inducible factors (HIFs), present 
in virtually all human cells, has been well-established. The 
cells adapt to hypoxia with help of this factor. It exists as 
a heterodimer with 2 known subunits: HIF-1α or HIF-2α 
and HIF-1β. HIF is activated in hypoxic conditions but is 
entirely inactive when oxygen is present  [25–28] . In hy-
poxic conditions, HIF subunits translocate to the nucleus, 
where they bind as heterodimers to a hypoxia response 
promoter element, inducing transcription of numerous 
genes, including those of nuclear factor-κB (NF-κB) and 
toll-like receptors ( fig.  1 ). In normoxaemic conditions, 
HIF is targeted by proteosomal degradation. Several ef-
fector targets responding to hypoxia have previously been 
identified, among them targets associated to the genera-
tion of ATP, oxidative stress, iron absorption and im-
mune responses  [29–36] .
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 Inflammatory bowel disease (IBD) is a chronic, often 
debilitating intestinal disorder  [37, 38] . The etiology of 
IBD has not yet been fully elucidated; however, results of 
multiple studies point to a role of dysregulated innate and 
adaptive immune responses to intestinal bacteria as well 
as environmental factors, usually subsumized as expo-
some  [39] . In IBDs such as Crohn’s disease (CD) and ul-
cerative colitis (UC), HIF seems also to play a crucial role. 
Expression of HIF was found to be elevated in inflamed 
colonic mucosal biopsies of patients with UC and CD on 
the RNA level  [14, 15] as well as on the protein level  [16] . 
HIF appears to stimulate gene expression with regards to 
proteins involved in the maintenance of epithelial barrier 
integrity and function  [15, 16] . Thus, the transcriptional 
profile as a sequel of HIF expression ultimately exerts a 
protective role for the epithelium during inflammation. 
A mouse model with decreased expression of HIF-1 
showed a more severe phenotype of colitis induced by 
trinitrobenzene sulfuric acid (TNBS), including an in-
creased weight loss and symptoms as well as an increase 
in epithelial permeability and ultimately mortality, 
whereas overexpression of HIF revealed to be protective 
against the TNBS-induced damage  [15] . Moreover, the 
NF-κB, a key factor in the hyperactivation of effector im-
mune cells in the pathogenesis of IBD, seems to be associ-
ated to tissue oxygenation, as tissue ischemia and reperfu-
sion was shown to promote its expression in mice  [40] . 
With regard to general intestinal function, both intestinal 
absorption and permeability were shown to be modified 
by environmental oxygen concentration  [41, 42] . More-
over, hypoxic conditions were shown to directly affect 
electrical currents when applied to the intestinal tissue 
from the serosa side  [43] , suggesting a direct effect of ox-
ygen concentration on ion transport in the gut epitheli-
um. Intriguingly, the induction of ‘hypoxia-type’ signal-
ing by the inflammatory microenvironment in colitis has 
been observed, a phenomenon commonly referred to as 
‘inflammatory hypoxia’  [20, 44] .
 Stimulated by various reports from our IBD patients 
experiencing increasing disease activity after aircraft 
travel and high altitude stays, we initiated a retrospective 
study to investigate a potential epidemiological associa-
tion between exposure to hypoxia and disease worsening 
in IBD  [45] . In this retrospective study in 103 patients 
with IBD (50 with CD and 43 with UC), all participants 
were grouped into those previously having had a flare of 
disease (52 patients) versus those patients in sustained 
remission (51 patients). While in the former group 21 pa-
tients reported an aircraft travel or a high altitude sojourn 
(defined as above 2,000 m) within 4 weeks prior to the 
 Fig. 1.  Regulation of HIF-1 according to the 
presence of oxygen. In the presence of oxy-
gen HIF-1α protein is hydroxylated and 
susceptible to binding to other proteins, 
such as the E3 ubiquitin ligase VHL (von 
Hippel Lindau) complex, ultimately lead-
ing to proteasomal degradation. In hypox-
ia, enzymes enabling VHL to bind to HIF-
1α are inhibited, precluding attachment of 
VHL to HIF-1α, which results in stabiliza-
tion of the latter. Stabilized HIF-1α the may 
translocate to the nucleus of the cell, where 
binding with HIF-1β occurs. This binding 
results in the formation of a heterodimer, 
which binds to the hypoxia-responsive ele-
ments (HREs). The latter contains the core 
sequence 5’-(A/G)CGTG-3’ of the HIF-re-
sponsive genes. Among the genes regulated 
by HRE are those involved in angiogenesis 
(to increase oxygen supply), metabolism or 
apoptosis. 
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flare, only 8 patients stated such an exposure to high alti-
tude in the latter group with sustained remission. This 
difference was significant in all IBD patients as well as CD 
patients, whereas a clear trend could be observed in those 
with UC. Interestingly, this association appeared to be 
even more pronounced in long-distant flights (i.e., those 
above 6 h) as well as in high altitude stays of longer dura-
tion and those above 3,000 m  [45] . Interestingly, at sea 
level, the oxygen fraction in the ambient air is roughly 
21% with a pressure of 760 mm Hg. During airplane 
flights, the partial pressure of oxygen in the cabin is nei-
ther similar to the ambient pressure present on the alti-
tude of the flight nor ground level, but reduced propor-
tionally to the decrease in air pressure, which is techni-
cally maintained in the cabin and not permitted to fall 
lower than the ambient air pressure at 2,438 m (8,000 ft; 
equaling 564 mm Hg), as required by international laws 
 [46] . According to systematic investigations, the cabin air 
pressure during flight virtually always remains in the 
range between 1,524 m (5,000 ft, 632 mm Hg) and the 
lowest permitted pressure (equaling 2,438 m ambient air) 
with a mean pressure value of 604 mm Hg (1,894 m)  [47] . 
This increase in altitude (and decrease in oxygen partial 
pressure) corresponds to an inspirational oxygen fraction 
of 15.1% (2,438 m) to 17.1% (1,524 m) at sea level. Con-
secutively, this decrease in ambient oxygen partial pres-
sure translates into a considerable decrease in the oxygen 
saturation in the peripheral blood (85 and 91%, respec-
tively) and mean arterial oxygen pressure (53 and 64 mm 
Hg, respectively), nota bene in healthy volunteers  [48] . In 
healthy subjects, this decrease in oxygen saturation is well 
tolerated in most instances, whereas hypoxia during air-
craft travel may induce discomfort and medical compli-
cations in patients with pulmonary diseases  [49] .
 While our study on increased activity in IBD patients 
after exposure to hypoxia  [45] indeed revealed a signifi-
cant association between inflammation and hypoxia, 
there are currently no clinical studies available in the lit-
erature. No studies have prospectively investigated a po-
tential impact of hypoxia and hypoxemia on the clinical 
course of disease as well as biomolecular features. To eval-
uate the potential influence of hypoxia on the course of 
IBD on a biomolecular level and to test the effects of hy-
poxia under standardized conditions, we initiated a pro-
spective and controlled investigation in both healthy con-
trols and IBD patients in stable remission. Ten healthy 
volunteers, 10 CD patients and 10 UC patients underwent 
a 3-hour exposure to hypoxic conditions simulating an 
altitude of 4,000 m above sea level in a hyperbaric pres-
sure chamber situated at the Swiss aeromedical centers in 
Dubendorf, Switzerland. This study had been fully ap-
proved by the local ethics committee (EK 2013-0284). 
Stool samples analyzing calprotectin and microbiotal 
composition, biopsy samples from the rectosigmoid re-
gion and blood samples were repetitively collected and 
analyzed in conjunction with detailed records of clinical 
symptoms. At the moment, the study is closed and data 
are being evaluated. The first results are expected by the 
middle of 2016.
 Conclusion 
 The importance of environmental factors in the patho-
genesis including their disease modifying potential are 
increasingly recognized in IBD, largely driven by the per-
ception that the prevalence and incidence of IBD are on 
the rise within the last few years, especially in non-west-
ern countries. Not only in these parts of the world, but 
also in Europe and North America, there have been sub-
stantial changes in environmental and life style factors, 
above all – but not exclusively – with regards to nutri-
tional intake, often referred to as westernization, while 
the genetic pool has only modestly been subject to chang-
es within that period. So far, the knowledge on the poten-
tial role of hypoxia in IBD is only scarce, despite both, 
numerous investigations in animal models and human, 
suggesting that hypoxia has a profound influence on the 
integrity and function of the gastrointestinal tract, epithe-
lial barrier, immune system and microbial composition 
as well as the increasing body of evidence, that exposure 
to hypoxia (airline travel and high-altitude stopover) may 
be associated with various gastrointestinal symptoms and 
signs and furthermore has an impact on the course of dis-
ease in IBD.
 Determining the mechanisms underlying these asso-
ciations and the potential interplay of these factors are 
crucial to prevent and treat deleterious effects of hypoxia 
in IBD patients with future high-altitude sojourn. How-
ever, hypoxia and hypoxemia may indeed be occurring 
during exposure to ambient air with normal oxygen par-
tial pressures. For instance, as a result of the altered phys-
iology within the intestinal barrier in patients with IBD 
exposed to normobaric ambient air local hypoxemia is 
highly likely to be present, at least intermittently, such as 
for instance due to increased oxygen extraction as a result 
of altered metabolic properties in inflammation or im-
paired oxygen delivery due to alterations in vascular ar-
chitecture as a sequel of tissue fibrosis, edema or anteced-
ent surgical intervention.
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 Thus, we consider our proposed research of impor-
tance for the general (‘sea-level’) IBD patient. Under-
standing molecular and microbiological consequences of 
intestinal hypoxia may ultimately derive further insights 
on the pathogenesis of IBD, far beyond exposure to lower 
partial oxygen pressure ambient air.
 Disclosure Statement 
The authors declare no disclosures. 
 1 Rosenberger P, Schwab JM, Mirakaj V, 
Masekowsky E, Mager A, Morote-Garcia JC, et 
al: Hypoxia-inducible factor-dependent induc-
tion of netrin-1 dampens inflammation caused 
by hypoxia. Nat Immunol 2009; 10: 195–202. 
 2 Eckle T, Faigle M, Grenz A, Laucher S, 
Thompson LF, Eltzschig HK: A2B adenosine 
receptor dampens hypoxia-induced vascular 
leak. Blood 2008; 111: 2024–2035. 
 3 Eltzschig HK, Ibla JC, Furuta GT, Leonard 
MO, Jacobson KA, Enjyoji K, et al: Coordinat-
ed adenine nucleotide phosphohydrolysis and 
nucleoside signaling in posthypoxic endothe-
lium: role of ectonucleotidases and adenosine 
A2B receptors. J Exp Med 2003; 198: 783–796. 
 4 Thompson LF, Eltzschig HK, Ibla JC, Van De 
Wiele CJ, Resta R, Morote-Garcia JC, et al: 
Crucial role for ecto-5 ′ -nucleotidase (CD73) 
in vascular leakage during hypoxia. J Exp Med 
2004; 200: 1395–1405. 
 5 Eltzschig HK, Abdulla P, Hoffman E, Hamil-
ton KE, Daniels D, Schönfeld C, et al: HIF-
1-dependent repression of equilibrative nu-
cleoside transporter (ENT) in hypoxia. J Exp 
Med 2005; 202: 1493–1505. 
 6 Hartmann G, Tschöp M, Fischer R, Bidling-
maier C, Riepl R, Tschöp K, et al: High alti-
tude increases circulating interleukin-6, in-
terleukin-1 receptor antagonist and C-reac-
tive protein. Cytokine 2000; 12: 246–252. 
 7 Wojtal KA, Cee A, Lang S, Götze O, Frühauf 
H, Geier A, et al: Downregulation of duode-
nal SLC transporters and activation of proin-
flammatory signaling constitute the early re-
sponse to high altitude in humans. Am J 
Physiol Gastrointest Liver Physiol 2014; 
 307:G673–G688. 
 8 Aeberli I, Erb A, Spliethoff K, Meier D, Götze 
O, Frühauf H, et al: Disturbed eating at high 
altitude: influence of food preferences, acute 
mountain sickness and satiation hormones. 
Eur J Nutr 2013; 52: 625–635. 
 9 Siebenmann C, Bloch KE, Lundby C, Nuss-
bamer-Ochsner Y, Schoeb M, Maggiorini M: 
Dexamethasone improves maximal exercise 
capacity of individuals susceptible to high al-
titude pulmonary edema at 4559 m. High Alt 
Med Biol 2011; 12: 169–177. 
 10 Anand AC, Sashindran VK, Mohan L: Gas-
trointestinal problems at high altitude. Trop 
Gastroenterol 2006; 27: 147–153. 
 11 Wu TY, Ding SQ, Liu JL, Jia JH, Dai RC, Zhu 
DC, et al: High-altitude gastrointestinal 
bleeding: an observation in Qinghai-Tibetan 
railroad construction workers on Mountain 
Tanggula. World J Gastroenterol 2007; 13: 
 774–780. 
 12 Fruehauf H, Erb A, Maggiorini M, Lutz TA, 
Schwizer W, Fried M, et al: T1080 unsedated 
transnasal esophago-gastroduodenoscopy at 
4559 m (14957 ft) – endoscopic findings in 
healthy mountaineers after rapid ascent to 
high altitude. Gastroenterology 2010;  138: 
 S483–S484. 
 13 Thornton RD, Lane P, Borghaei RC, Pease 
EA, Caro J, Mochan E: Interleukin 1 induces 
hypoxia-inducible factor 1 in human gingival 
and synovial fibroblasts. Biochem J 2000; 
 350(pt 1):307–312. 
 14 Vermeulen N, Vermeire S, Arijs I, Michiels 
G, Ballet V, Derua R, et al: Seroreactivity 
against glycolytic enzymes in inflammatory 
bowel disease. Inflamm Bowel Dis 2011; 17: 
 557–564. 
 15 Karhausen J, Furuta GT, Tomaszewski JE, 
Johnson RS, Colgan SP, Haase VH: Epithelial 
hypoxia-inducible factor-1 is protective in 
murine experimental colitis. J Clin Invest 
2004; 114: 1098–1106. 
 16 Giatromanolaki A, Sivridis E, Maltezos E, Pa-
pazoglou D, Simopoulos C, Gatter KC, et al: 
Hypoxia inducible factor 1alpha and 2alpha 
overexpression in inflammatory bowel dis-
ease. J Clin Pathol 2003; 56: 209–213. 
 17 Shay JE, Imtiyaz HZ, Sivanand S, Durham 
AC, Skuli N, Hsu S, et al: Inhibition of hypox-
ia-inducible factors limits tumor progression 
in a mouse model of colorectal cancer. Carci-
nogenesis 2014; 35: 1067–1077. 
 18 Tsuzuki Y, Fukumura D, Oosthuyse B, Koike 
C, Carmeliet P, Jain RK: Vascular endothelial 
growth factor (VEGF) modulation by target-
ing hypoxia-inducible factor-1alpha – hypox-
ia response element – VEGF cascade differen-
tially regulates vascular response and growth 
rate in tumors. Cancer Res 2000; 60: 6248–
6252. 
 19 Krüger B, Krick S, Dhillon N, Lerner SM, 
Ames S, Bromberg JS, et al: Donor toll-like 
receptor 4 contributes to ischemia and reper-
fusion injury following human kidney trans-
plantation. Proc Natl Acad Sci U S A 2009; 
 106: 3390–3395. 
 20 Colgan SP, Taylor CT: Hypoxia: an alarm sig-
nal during intestinal inflammation. Nat Rev 
Gastroenterol Hepatol 2010; 7: 281–287. 
 21 Taylor CT, Colgan SP: Hypoxia and gastroin-
testinal disease. J Mol Med (Berl) 2007; 85: 
 1295–1300. 
 22 Pollard TD, Borisy GG: Cellular motility driv-
en by assembly and disassembly of actin fila-
ments. Cell 2003; 112: 453–465. 
 23 Borregaard N, Herlin T: Energy metabolism 
of human neutrophils during phagocytosis. J 
Clin Invest 1982; 70: 550–557. 
 24 Gabig TG, Bearman SI, Babior BM: Effects of 
oxygen tension and pH on the respiratory 
burst of human neutrophils. Blood 1979; 53: 
 1133–1139. 
 25 Semenza GL: Life with oxygen. Science 2007; 
 318: 62–64. 
 26 Kaelin WG Jr, Ratcliffe PJ: Oxygen sensing by 
metazoans: the central role of the HIF hydrox-
ylase pathway. Mol Cell 2008; 30: 393–402. 
 27 Fandrey J, Gorr TA, Gassmann M: Regulating 
cellular oxygen sensing by hydroxylation. 
Cardiovasc Res 2006; 71: 642–651. 
 28 Greer SN, Metcalf JL, Wang Y, Ohh M: The 
updated biology of hypoxia-inducible factor. 
EMBO J 2012; 31: 2448–2460. 
 29 Bosco MC, Puppo M, Blengio F, Fraone T, 
Cappello P, Giovarelli M, et al: Monocytes 
and dendritic cells in a hypoxic environment: 
spotlights on chemotaxis and migration. Im-
munobiology 2008; 213: 733–749. 
 30 Brahimi-Horn MC, Chiche J, Pouysségur J: 
Hypoxia signalling controls metabolic de-
mand. Curr Opin Cell Biol 2007; 19: 223–229. 
 31 Franke K, Gassmann M, Wielockx B: Eryth-
rocytosis: the HIF pathway in control. Blood 
2013; 122: 1122–1128. 
 32 Mastrogiannaki M, Matak P, Keith B, Simon 
MC, Vaulont S, Peyssonnaux C: HIF-2alpha, 
but not HIF-1alpha, promotes iron absorption 
in mice. J Clin Invest 2009; 119: 1159–1166. 
 33 Nizet V, Johnson RS: Interdependence of hy-
poxic and innate immune responses. Nat Rev 
Immunol 2009; 9: 609–617. 
 34 Pialoux V, Mounier R, Brown AD, Steinback 
CD, Rawling JM, Poulin MJ: Relationship be-
tween oxidative stress and HIF-1 alpha 
mRNA during sustained hypoxia in humans. 
Free Radic Biol Med 2009; 46: 321–326. 
 35 Semenza GL: Oxygen sensing, homeostasis, 
and disease. N Engl J Med 2011; 365: 537–547. 
 36 Wang Q, Liu C, Zhu F, Liu F, Zhang P, Guo C, 
et al: Reoxygenation of hypoxia-differentiated 
dentritic cells induces Th1 and Th17 cell dif-
ferentiation. Mol Immunol 2010; 47: 922–931. 
 References 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
25
 - 
2/
13
/2
01
7 
3:
27
:1
1 
PM
 Hypoxia in IBD Dig Dis 2016;34:78–83
DOI: 10.1159/000442932
83
 37 Vavricka SR, Rogler G: New insights into the 
pathogenesis of Crohn’s disease: are they rel-
evant for therapeutic options? Swiss Med 
Wkly 2009; 139: 527–534. 
 38 Vavricka SR, Rogler G: Recent advances in the 
etiology and treatment of Crohn’s disease. 
Minerva Gastroenterol Dietol 2010; 56: 203–
211. 
 39 Rogler G, Vavricka S: Exposome in IBD: re-
cent insights in environmental factors that in-
fluence the onset and course of IBD. Inflamm 
Bowel Dis 2015; 21: 400–408. 
 40 Chen LW, Egan L, Li ZW, Greten FR, Kagnoff 
MF, Karin M: The two faces of IKK and NF-
kappaB inhibition: prevention of systemic in-
flammation but increased local injury follow-
ing intestinal ischemia-reperfusion. Nat Med 
2003; 9: 575–581. 
 41 Kles KA, Tappenden KA: Hypoxia differen-
tially regulates nutrient transport in rat jeju-
num regardless of luminal nutrient present. 
Am J Physiol Gastrointest Liver Physiol 2002; 
 283:G1336–G1342. 
 42 Kles KA, Wallig MA, Tappenden KA: Lumi-
nal nutrients exacerbate intestinal hypoxia in 
the hypoperfused jejunum. JPEN J Parenter 
Enteral Nutr 2001; 25: 246–253. 
 43 Carra GE, Ibáñez JE, Saraví FD: Electrogenic 
transport, oxygen consumption, and sensitiv-
ity to acute hypoxia of human colonic epithe-
lium. Int J Colorectal Dis 2011; 26: 1205–1210. 
 44 Eltzschig HK, Carmeliet P: Hypoxia and in-
flammation. N Engl J Med 2011; 364: 656–665. 
 45 Vavricka SR, Rogler G, Maetzler S, Misselwitz 
B, Safroneeva E, Frei P, et al: High altitude 
journeys and flights are associated with an in-
creased risk of flares in inflammatory bowel 
disease patients. J Crohns Colitis 2014; 8: 191–
199. 
 46 Code of Federal Regulations: Title 14: Part 
25.841. Washington Government Printing 
Office, 1986. 
 47 Cottrell JJ: Altitude exposures during aircraft 
flight. Flying higher. Chest 1988; 93: 81–84. 
 48 British Thoracic Society Standards of Care 
Committee: Managing passengers with respi-
ratory disease planning air travel: British tho-
racic society recommendations. Thorax 2002; 
 57: 289–304. 
 49 Tzani P, Pisi G, Aiello M, Olivieri D, Chetta 
A: Flying with respiratory disease. Respira-
tion 2010; 80: 161–170. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
25
 - 
2/
13
/2
01
7 
3:
27
:1
1 
PM
